Continuous Renal Replacement Therapy: Cause and Treatment of Electrolyte Complications

Seminars in Dialysis

Volumn 23, Issue 6, 2010, Pages 581-585

  Fall, Pamela ^a   Szerlip, Harold M ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CRITICAL ILLNESS; ELECTROLYTE BALANCE; HEALTH; HUMAN; INCIDENCE; METABOLIC DISORDER; METABOLISM; RENAL REPLACEMENT THERAPY; RISK FACTOR;

CRITICAL ILLNESS; HUMANS; INCIDENCE; RENAL REPLACEMENT THERAPY; RISK FACTORS; WATER-ELECTROLYTE BALANCE; WATER-ELECTROLYTE IMBALANCE; WORLD HEALTH;

EID: 78650312123     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00790.x     Document Type: Article

References (36)

1. Morimatsu H, Uchino S, Bellomo R, Ronco C: Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations. Int J Artif Organs 25:512-519, 2002.
2. Marshall MR, Golper TA, Shaver MJ, Alam MG, Chatoth DK: Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int 60:777-785, 2001
3. Ratanarat R, Brendolan A, Volker G, Bonello M, Salvatori G, Andrikos E, Yavuz A, Crepaldi C, Ronco C: Phosphate kinetics during different dialysis modalities. Blood Purif 23:83-90, 2005
4. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7-20, 2008
5. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J, Norton R, Scheinkestel C, Su S: Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627-1638, 2009
6. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M: Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med 30:1662-1665, 2004
7. Santiago MJ, Lopez-Herce J, Urbano J, Bellon JM, del Castillo J, Carrillo A: Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 75:312-316, 2009
8. Rocktaschel J, Morimatsu H, Uchino S, Ronco C, Bellomo R: Impact of continuous veno-venous hemofiltration on acid-base balance. Int J Artif Organs 26:19-25, 2003
9. Davenport A: The coagulation system in the critically ill patient with acute renal failure and the effect of an extracorporeal circuit. Am J Kidney Dis 30:S20-S27, 1997
10. Cutts MW, Thomas AN, Kishen R: Transfusion requirements during continuous veno-venous haemofiltration: -the importance of filter life. Intensive Care Med 26:1694-1697, 2000
11. van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC: Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 7:145-150, 1996
12. Daugirdas JT, Blake PG, Ing TS (Ed.): Handbook of Dialysis, 4th ed. Lippincott: Williams and Wilkins, 2006:239-243
13. Tan HK, Baldwin I, Bellomo R: Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 26:1652-1657, 2000
14. Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T: Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system J Crit Care 20:155-161, 2005
15. Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL: Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416-1421, 2005
16. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 67:2361-2367, 2005
17. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P: Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30:260-265, 2004
18. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, van der Voort PH, Wester JP, van der Spoel JI, Dijksman LM, Zandstra DF: Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 37:545-552, 2009
19. Bihorac A, Ross EA: Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Am J Kidney Dis 46:908-918, 2005
20. Cassina T, Mauri R, Engeler A, Giannini O: Continuous veno-venous hemofiltration with regional citrate anticoagulation: a four-year single-center experience. Int J Artif Organs 31:937-943, 2008
21. Egi M, Naka T, Bellomo R, Langenberg CC, Li W, Fealy N, Baldwin I: The acid-base effect of changing citrate solution for regional anticoagulation during continuous veno-venous hemofiltration. Int J Artif Organs 31:228-236, 2008
22. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG: Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60:370-374, 2001
23. Swartz R, Pasko D, O'Toole J, Starmann B: Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation. Clin Nephrol 61:134-143, 2004
24. Gupta M, Wadhwa NK, Bukovsky R: Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Am J Kidney Dis 43:67-73, 2004
25. Morgera S, Haase M, Ruckert M, Krieg H, Kastrup M, Krausch D, Vargas-Hein O, Zuckermann-Becker H, Peters H, Pohlmeier R, Neumayer HH: Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 101:c211-c219, 2005
26. Finkel KW, Foringer JR: Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients. Ren Fail 27:541-545, 2005
27. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55:1991-1997, 1999
28. Bakker AJ, Boerma EC, Keidel H, Kingma P, van der Voort PH: Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med 44:962-966, 2006
29. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29:748-752, 2001
30. Huang WY, Weng WC, Peng TI, Ro LS, Yang CW, Chen KH: Central pontine and extrapontine myelinolysis after rapid correction of hyponatremia by hemodialysis in a uremic patient. Ren Fail 29:635-638, 2007
31. Ji DX, Gong DH, Xu B, Tao J, Ren B, Zhang YD, Liu Y, Hu WX, Wang MM, Li LS: Continuous veno-venous hemofiltration in the treatment of acute severe hyponatremia: a report of 11 cases. Int J Artif Organs 30:176-180, 2007
32. Kahn A, Brachet E, Blum D: Controlled fall in natremia and risk of seizures in hypertonic dehydration. Intensive Care Med 5:27-31, 1979
33. McBryde KD, Bunchman TE, Kudelka TL, Pasko DA, Brophy PD: Hyperosmolar solutions in continuous renal replacement therapy for hyperosmolar acute renal failure: a preliminary report. Pediatr Crit Care Med 6:220-225, 2005
34. Yang YF, Wu VC, Huang CC: Successful management of extreme hypernatraemia by haemofiltration in a patient with severe metabolic acidosis and renal failure. Nephrol Dial Transplant 20:2013-2014, 2005
35. Hilton PJ, Taylor J, Forni LG, Treacher DF: Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. QJM 91:279-283, 1998
36. Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D: Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 25:58-62, 1997